Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-23T21:43:28.763Z Has data issue: false hasContentIssue false
  • English
  • Français

Spontaneous Temporary Remission in Primary CNS Lymphoma

Published online by Cambridge University Press:  18 September 2015

Michael Rubin ,
Israel Libman ,
Marie-Laure Brisson ,
Marvin Goldenberg  and
Steven Brem
Michael Rubin
Affiliation:
Department of Neuroscience, The Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal
Israel Libman*
Affiliation:
Department of Neuroscience, The Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal
Marie-Laure Brisson
Affiliation:
Department of Pathology, The Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal
Marvin Goldenberg
Affiliation:
Department of Neuroradiology, The Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal
Steven Brem
Affiliation:
Department of Neuroscience, The Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal
*
Sir Mortimer B. Davis-Jewish General Hospital, 3755 Cote Ste. Catherine, Montreal, Quebec, Canada H3T IE2
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We report a case of primary CNS lymphoma in which complete, though temporary, spontaneous clinical and radiologic remission occurred. This is the first such case report to our knowledge.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 14 , Issue 2 , May 1987 , pp. 175 - 177
Copyright
Copyright © Canadian Neurological Sciences Federation 1987

References

1.Freeman, C, Berg, JW, Cutler, SJ.Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–60.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
2.Henry, JM, Heffner, RR, Dillard, SH, et al. Primary malignant lymphomas of the central nervous system. Cancer 1974; 34: 1293–1302.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
3.Burnstein, S, Kernohan, J, Uihlein, A.Neoplasms of the reticuloendothelial system of the brain. Cancer 1963: 16: 290–305.Google Scholar
4.Schaumburg, HH, Plank, CR, Adams, RD.The reticulum cell sarcoma microglioma group of brain tumours: A consideration of their clinical features and therapy. Brain 1972; 95: 199–212.CrossRefGoogle ScholarPubMed
5.Williams, RS, Crowell, RM, Fisher, CM, et al.Clinical and radiologic remission in reticulum cell sarcoma of the brain. Arch Neurol 1979; 36: 206–10.CrossRefGoogle ScholarPubMed
6.Singh, A, Strobos, RJ, Singh, BM, et al.Steroid induced remissions in CNS lymphoma. Neurology (NY) 1982: 32: 1267–71.CrossRefGoogle ScholarPubMed
7.Weingarten, KL, Zimmerman, RD, Leeds, NE.Spontaneous regression of intracerebral lymphoma. Radiology 1983; 149: 721–24.CrossRefGoogle ScholarPubMed
8.Minot, GR, Isaacs, R.Lymphoblastoma (malignant lymphoma): age and sex incidence, duration of disease, and the effect of roentgen ray and radium irradiation and surgery. JAMA 1926: 86: 1185–89, 1265–70CrossRefGoogle Scholar
9.Gall, EA, Mallory, TB.Malignant lymphoma: a clinical pathological survey of 618 cases. Am J Pathol 1942; 18: 381–429.Google Scholar
10.Everson, TC.Spontaneous regression of human tumours. In: Ariel, IM, ed. Progress in Clinical Cancer. Vol 3 New York, Grune and Stratton Inc. 1967: 79–95.Google Scholar
11.Baxter, JD, Harris, AW, Tomkins, GM, et al.Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science 1971; 171: 189–91.CrossRefGoogle ScholarPubMed
12.Sherbet, GV, Lakshmi, MS, Haddad, SK.Does dexamethasone inhibit the growth of human gliomas? J Neurosurg 1977; 47: 864–70.CrossRefGoogle ScholarPubMed
13.Claman, HN.Corticosteroids and lymphoid cells. N Engl J Med 1972; 287: 388–97.CrossRefGoogle ScholarPubMed
14.Bloomfield, CD, Smith, KA, Peterson, BA, et al.In vitro glucocorticoid studies for predicting response to glucocorticoid therapy in adults with malignant lymphoma. Lancet 1980; 1: 952–56.CrossRefGoogle ScholarPubMed
15.Bloomfield, CD, Smith, KA, Peterson, BA, et al.In vitro glucocorticoid studies in human lymphoma: clinical and biologic significance. J Steroid Biochem 1981; 15: 275–84.CrossRefGoogle ScholarPubMed
16.Bloomfield, CD.Glucocorticoid receptors in leukemia and lymphoma. J Clin Oncol 1984; 2: 323–28.CrossRefGoogle ScholarPubMed